13 days ago · Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares rose 6% on Tuesday . The stock traded as high as $36.10 and last traded at $36.09, approximately 591,117 shares changed hands during trading. A decline of 18% from the average daily volume of 718,642 shares. The stock had previously closed at $34.04. AGIO has been the topic of several […] 3 Top Healthcare Stocks That Could Gain 35% -- Or More Jan 17, 2020 · A potential twelve-month climb of 24% could be in the cards given the $62.43 average price target. (See Agios stock analysis on TipRanks) Daré Bioscience Agios Pharmaceuticals Inc : AGIO Stock Price Quote at Ally ...
Stockopedia rates Agios Pharmaceuticals Inc as a Adventurous Style Neutral . 7 brokers rate it as StockRank™ · StockReport™ Price Target: ( below Price).
Agios Pharmaceuticals, Inc. - AGIO - Stock Price Today - Zacks View Agios Pharmaceuticals, Inc. AGIO investment & stock information. Get the latest Agios Pharmaceuticals, Inc. AGIO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Agios stock: buy or sell? - AGIO Agios stock historical price chart. AGIO stock reached 52-week highs on April at $68.89, and all-time highs 2015-01-15 with a price of 138.85. Agios stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and
Agios stock historical price chart. AGIO stock reached 52-week highs on April at $68.89, and all-time highs 2015-01-15 with a price of 138.85. Agios stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and
27 Sep 2019 At the beginning of that period, biotech stocks had low valuations, and there had been years with a dearth of new stock issuances. When David was CEO of Agios Pharmaceuticals [AGIO], which Our price target is $88. 13 Jun 2016 Canaccord Genuity analyst John Newman upgraded Agios Pharma stock to buy from hold, lifting his price target to 90 from 50, writing that the 20 Jul 2018 Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in $46.90Stock is0 (0.00%) TIBSOVO®, an oral, targeted inhibitor of the IDH1 enzyme, is the first and only FDA-approved 16 May 2019 The stock has a consensus analyst price target of $24.50. Shares of Agios closed up 5% at $49.74, with a 52-week range of $41.63 to $99.82
Mar 12, 2020 · The Healthcare company has also assigned a $50 price target. Barclays wasn’t the only research firm that published a report of Agios Pharmaceuticals Inc., with other equities research analysts also giving their opinion on the stock.
AGIO Price Target | Agios Pharma Stock Forecast & Ratings See Agios Pharma price target based on 8 analysts offering 12 month price targets for Agios Pharma in the last 3 months. The average price target is $66.00 with a high forecast of $72.00 and a low forecast of $42.00. The average price target represents a 77.23% increase from the last price of $37.24. Agios (AGIO) Surges More Than 40% Year to Date: Here's Why ... Shares of Agios Pharmaceuticals, Inc. (AGIO - Free Report) have witnessed a sharp rise in the year so far.In fact, the company’s stock has soared 43%, outperforming the industry’s increase of Agios Pharmaceuticals (NASDAQ:AGIO) - Cantor Fitzgerald ... Feb 14, 2020 · This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals, Raises
Agios Pharmaceuticals, Inc. (AGIO) stock price, quote ...
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology for the treatment of hematologic malignancies, solid tumors, and rare genetic diseases in the United States.